Skip to content

Profile of COVID-19 Patients Related to Fatigue

Profile of COVID-19 Patients Related to Fatigue

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05731817
Enrollment
398
Registered
2023-02-16
Start date
2023-02-15
Completion date
2026-09-30
Last updated
2026-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

COVID-19, fatigue

Brief summary

More than half of recovered COVID-19 patients experience fatigue. Studies are needed to define the profile of these patients. The objective of this study is to evaluate the profile of surviving patients of COVID-19 in relation to fatigue.

Detailed description

Background: More than half of recovered COVID-19 patients experience fatigue. Studies are needed to define the profile of these patients. Objectives: Evaluate the profile of surviving patients of COVID-19 in relation to fatigue; Methodology: Observational study. The profile of the survivors of COVID-19 will be described, dividing them into 2 groups based on the presence or absence of fatigue. Patients will be recruited from the Virgen de las Nieves University Hospital in Granada. The evaluation will be carried out through Google forms, telematic means or face-to-face depending on the variables. A symptomatic evaluation of fatigue, aspects related to fatigue and physical performance will be carried out.

Interventions

OTHERObservational study

N/A - observational study.

Sponsors

Universidad de Granada
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of COVID-19 * adults (\>18 years) * basic knowledge and access to the internet * wish to participate in the study and sign the informed consent

Exclusion criteria

* patients with severe comorbidities that interfere with the ability to perform the study, and those with mental, physical or organic problems that under medical criteria may pose a risk to the patient

Design outcomes

Primary

MeasureTime frameDescription
Perceived FatigueThrough study completion, an average of 1 yearTo assess perceived fatigue using the borg modified scale. Scale ranges from 0 to 10, with higher punctuation indicating higher fatigue perception.
Multidimensional FatigueThrough study completion, an average of 1 yearTo assess multidimensional fatigue using the multidimensional fatigue inventory
Fatigue SeverityThrough study completion, an average of 1 yearTo assess fatigue severity using the fatigue severity scale. The total score ranges from 7 to 63 points, with higher punctuation indicating higher fatigue severity
Fatigue ImpactThrough study completion, an average of 1 yearTo assess fatigue impact using the modified fatigue impact scale. All items are scaled so that higher scores indicate a greater impact of fatigue on a person's activities. This scale can range from 0 to 36.
Muscular FatigueThrough study completion, an average of 1 yearTo assess muscular fatigue using surface electromyography

Secondary

MeasureTime frameDescription
COVID-19 informationThrough study completion, an average of 1 yearTo assess information about the date and symptoms when COVID-19 was diagnosed
DyspneaThrough study completion, an average of 1 yearTo assess Dyspnea perception using the borg modified scale
CoughThrough study completion, an average of 1 yearTo assess cough using the leicester cough questionnaire
Pain intensityThrough study completion, an average of 1 yearTo assess pain intensity using the visual analogue scale and brief pain inventory
Functional statusThrough study completion, an average of 1 yearTo assess functional status using the post-covid functional scale and functional independence measure
FrailtyThrough study completion, an average of 1 yearTo assess frailty using the clinical frailty scale
Health-related Quality of lifeThrough study completion, an average of 1 yearTo assess health-related quality of life using the euroqol-5d
Psychological statusThrough study completion, an average of 1 yearTo assess Psychological status using the hospital anxiety and depression scale
Sleep qualityThrough study completion, an average of 1 yearTo assess sleep quality using the Pittsburgh Sleep Quality Index
Nutritional statusThrough study completion, an average of 1 yearTo assess nutritional status using the mini nutritional assessment
Physical activityThrough study completion, an average of 1 yearTo assess physical activity using the international physical activity questionnaire. This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in Metabolic Equivalent (MET)-min/week and time spent sitting.
KinesiophobiaThrough study completion, an average of 1 yearTo assess kinesiophobia using the TAMPA scale
Exercise capacityThrough study completion, an average of 1 yearTo assess exercise capacity using the Short Physical Performance Battery and the 6 minutes walk test
StrengthThrough study completion, an average of 1 yearTo assess strength using dynamometry
Heart rate variabilityThrough study completion, an average of 1 yearTo assess heart rate variability using holter

Countries

Spain

Contacts

PRINCIPAL_INVESTIGATORIrene Torres Sánchez, PhD

Universidad de Granada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 1, 2026